Pfizer said it still plans to release phase two trial data on a once-a-day version of its weight loss drug, known as danuglipron, in the first half of 2024.
Pfizer to discontinue twice-daily weight loss pill due to high rates of adverse side effects
Related Posts
ADVERTISEMENT
Browse by Category
- Abu Dhabi 阿布扎比
- Animals
- Beijing 北京
- Blog
- Bolivia 玻利维亚
- Building
- China 中国
- Dubai 迪拜
- Finance News
- Flowers
- Food
- Free Talk
- Fujian 福建
- Guangdong 广东
- Hebei 河北
- Henan 河南
- Hiking
- Hong Kong 香港
- Investment
- Jiangxi 江西
- Kids
- Kuala Lumpur 吉隆坡
- Landscape
- Liaoning 辽宁
- Life in BJ
- Machine Learning
- Malaysia 马来西亚
- Mongolia 蒙古
- Movie
- Peru 秘鲁
- Photo News
- Photography
- Portrait
- Shanghai 上海
- Snapshot
- South America 南美
- South Korea 南韩
- Star
- Taiwan 台湾
- Tianjin 天津
- Tibet 西藏
- Travel
- United Arab Emirates 阿聯酋
Subscribe to Blog via Email
Join 30 other subscribers.
© 2010-2022 Billy Tang
Supported By Growth SpeedUp Company